Glycolysis-dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X-ray responsive CO-releasing nanocomposite (HA@AuNC@CO) based on strong host-guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD-AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X-ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada-CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
Keyphrases
- cancer therapy
- reactive oxygen species
- papillary thyroid
- high resolution
- room temperature
- dual energy
- early stage
- dna damage
- squamous cell carcinoma
- radiation induced
- stem cells
- drug delivery
- carbon dioxide
- computed tomography
- young adults
- magnetic resonance imaging
- childhood cancer
- locally advanced
- oxidative stress
- quantum dots
- mesenchymal stem cells
- mass spectrometry
- highly efficient
- bone marrow
- ionic liquid
- replacement therapy
- fluorescent probe